The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Myelin regeneration is a major therapeutic goal in demyelinating diseases, and the failure to remyelinate rapidly has profound consequences for the health of axons and for brain function. However, there is no efficient treatment for stimulating myelin repair, and current therapies are limited to anti-inflammatory agents. Males are less likely to develop multiple sclerosis than females, but often have a more severe disease course and reach disability milestones at an earlier age than females, and these observations have spurred interest in the potential protective effects of androgens. Here, we demonstrate that testosterone treatment efficiently stimulates the formation of new myelin and reverses myelin damage in chronic demyelinated brain lesions, resulting from the long-term administration of cuprizone, which is toxic for oligodendrocytes. In addition to the strong effect of testosterone on myelin repair, the number of activated astrocytes and microglial cells returned to low control levels, indicating a reduction of neuroinflammatory responses. We also identify the neural androgen receptor as a novel therapeutic target for myelin recovery. After the acute demyelination of cerebellar slices in organotypic culture, the remyelinating actions of testosterone could be mimicked by 5α-dihydrotestosterone, a metabolite that is not converted to oestrogens, and blocked by the androgen receptor antagonist flutamide. Testosterone treatment also failed to promote remyelination after chronic cuprizone-induced demyelination in mice with a non-functional androgen receptor. Importantly, testosterone did not stimulate the formation of new myelin sheaths after specific knockout of the androgen receptor in neurons and macroglial cells. Thus, the neural brain androgen receptor is required for the remyelination effect of testosterone, whereas the presence of the receptor in microglia and in peripheral tissues is not sufficient to enhance remyelination. The potent synthetic testosterone analogue 7α-methyl-19-nortestosterone, which has been developed for long-term male contraception and androgen replacement therapy in hypogonadal males and does not stimulate prostate growth, also efficiently promoted myelin repair. These data establish the efficacy of androgens as remyelinating agents and qualify the brain androgen receptor as a promising drug target for remyelination therapy, thus providing the preclinical rationale for a novel therapeutic use of androgens in males with multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724 · cited 1×
“Both cell types indeed play key roles in myelin formation by producing trophic factors (Talbott et al., 2005; Trapp and Nave, 2008).”
BackgroundOligodendroglia metabolically support axons and contribute to neurodegeneration
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., et al. (2012) · Nature · doi:10.1038/nature11314 · Cited by 1,664 · cited 2×
“…in the present study is also supported by previous observations in adult and young mice (Jalabi et al., 2005; Harsan et al., 2008), and it can be accurately explained by the important role of oligodendroglia and myelin in the maintenance of healthy axons (Wake et al., 2011; Lee et al., 2012).”
ResultRemyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544 · cited 5×
“the early stages of multiple sclerosis, but with the progression of the disease, the capacity of myelin recovery decreases, possibly because of the failure of oligodendrocyte precursor cell recruitment and differentiation (Franklin and ffrench-Constant, 2008; Kuhlmann et al., 2008; Piaton et al., 2009).”
BackgroundInfluentialPremyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991 · cited 2×
“Remyelination involves the proliferation and maturation of oligodendrocyte precursor cells The remyelination of axons requires the generation of new oligodendrocytes from oligodendrocyte precursor cells (Chang et al., 2002; Franklin and ffrench-Constant, 2008).”
BackgroundMatsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984 · cited 3×
“Chronic brain demyelination and oligodendrocyte depletion were induced in mice by cuprizone intoxication for 12 weeks (Matsushima and Morell, 2001; Mason et al., 2004; Harsan et al., 2008).”
BackgroundHeemers, H. V., & Tindall, D. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0019 · Cited by 753
Malkin, C. J., Pugh, P. J., Jones, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031069 · Cited by 731
Control of local protein synthesis and initial events in myelination by action potentials
Wake, H., Lee, P. R., & Fields, R. D. (2011) · Science · doi:10.1126/science.1206998 · Cited by 636 · cited 2×
“…in the present study is also supported by previous observations in adult and young mice (Jalabi et al., 2005; Harsan et al., 2008), and it can be accurately explained by the important role of oligodendroglia and myelin in the maintenance of healthy axons (Wake et al., 2011; Lee et al., 2012).”
ResultThe cuprizone animal model: new insights into an old story
Kipp, M., Clarner, T., Dang, J., Copray, S., & Beyer, C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0591-3 · Cited by 481 · cited 2×
“Moreover, the model has been extremely useful for studying the biology of remyelination and for identifying factors and signalling mechanisms involved in this complex process (Blakemore and Franklin, 2008; Harsan et al., 2008; Kipp et al., 2009).”
BackgroundTripathi, R. B., Rivers, L. E., Young, K. M., Jamen, F., & Richardson, W. D. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3411-10.2010 · Cited by 277 · cited 2×
“They are recruited to areas of demyelination , where they proliferate and differentiate into myelin-forming cells (Chang et al., 2000; Tripathi et al., 2010).”
Background
Cited by
Praet, J., Guglielmetti, C., Berneman, Z., Van der Linden, A., & Ponsaerts, P. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.10.004 · Cited by 435
Itoh, N., Itoh, Y., Tassoni, A., Ren, E., Kaito, M., Ohno, A., Ao, Y., Farkhondeh, V., Johnsonbaugh, H., Burda, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716032115 · Cited by 253
Dulamea, A. O. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-47861-6_7 · Cited by 128
El-Etr, M., Rame, M., Boucher, C., Ghoumari, A. M., Kumar, N., Liere, P., Pianos, A., Schumacher, M., & Sitruk-Ware, R. (2015) · Glia · doi:10.1002/glia.22736 · Cited by 116
Self-citationThe effect of sex on multiple sclerosis risk and disease progression
Voskuhl, R. R. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458519892491 · Cited by 113
Metadata
- Authors
- Hussain, R., Ghoumari, A. M., Bielecki, B., Steibel, J., Boehm, N., Liere, P., Macklin, W. B., Kumar, N., Habert, R., Mhaouty-Kodja, S., Tronche, F., Sitruk-Ware, R., Schumacher, M., & Ghandour, M. S.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01
- Volume
- 136
- Issue
- 1
- Pages
- 132-146
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W1982287948
- Cited by
- 175
- References
- 19
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination. https://app.cochat.ai/papers/10.1093/brain/aws284
- The paper
- Hussain, R., Ghoumari, A. M., Bielecki, B., Steibel, J., Boehm, N., Liere, P., Macklin, W. B., Kumar, N., Habert, R., Mhaouty-Kodja, S., Tronche, F., Sitruk-Ware, R., Schumacher, M., & Ghandour, M. S. (2013). The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination. Brain. https://doi.org/10.1093/brain/aws284
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.